Ekso Bionics to Announce First Quarter Financial Results
Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) is gearing up to unveil its financial performance for the first quarter of 2025. The company specializes in cutting-edge exoskeleton technology designed for both medical and industrial fields. They will disclose their financial and operational results following the market close on a Monday, with management leading a conference call to discuss the specifics.
Details of the Conference Call
The conference call is scheduled to commence at 1:30 p.m. PT / 4:30 p.m. ET. Investors and interested parties will have the opportunity to hear direct insights from company leadership regarding the financial outcomes and other essential updates on their business progress.
How to Join the Conference Call
For those wishing to participate through a telephone call, the numbers to reach are 877-407-6184 for domestic calls and 201-389-0877 for international attendees. This setup allows for broader participation from various stakeholders and interested listeners who want to stay informed about Ekso Bionics’ initiatives and financial health.
Broadcasting the Call
The call will not only be accessible via phone but will also be live-streamed online. A recording of the session will be made available afterward on the Ekso Bionics website, under the “Presentations & Events” section. This ensures that anyone unable to attend in real-time still has access to the valuable information shared.
Who is Ekso Bionics?
Ekso Bionics is known as a pioneer in exoskeleton technology, striving to enhance human capabilities across multiple sectors. The company’s developments focus on supporting individuals with disabilities while also improving productivity and safety in industrial environments. Their devices are designed to empower users by restoring their mobility and enhancing their physical capabilities.
Impact of Their Technology
The innovative solutions provided by Ekso Bionics offer significant advantages. From aiding individuals with paralysis to enabling workers in physically demanding professions, these technologies bring about transformations that improve quality of life and workplace efficiency. Their commitment to advancing human function through robotics sets them apart in the industry.
Staying Updated on Ekso Bionics
As part of their dedication to transparent communication with their stakeholders, Ekso Bionics encourages interested parties to stay informed through their official channels. By engaging with the latest announcements and participating in scheduled discussions, investors can gain deeper insights into the company’s strategies and growth trajectory.
Contact Information
For any inquiries regarding investor relations, Stephen Kilmer is the designated contact, reaching him directly at (646) 274-3580. He is available to provide insights and respond to questions about the company’s performance and future directions. Additionally, he can be contacted via email, ensuring that investors and interested parties have the necessary resources to stay connected.
Frequently Asked Questions
1. When will Ekso Bionics announce their financial results?
Ekso Bionics plans to announce their Q1 2025 financial results on May 5, 2025, after market close.
2. How can I join the conference call?
To join the conference call, dial 877-407-6184 for domestic participants or 201-389-0877 for international participants.
3. Where can I find the archived conference call?
The archived conference call will be available on Ekso Bionics’ website under the “Presentations & Events” section.
4. What is the primary focus of Ekso Bionics?
Ekso Bionics specializes in developing exoskeleton solutions that enhance human mobility and capabilities in both medical and industrial settings.
5. Who can I contact for more information about the company?
For more information, Stephen Kilmer is the point of contact for investor relations, available at (646) 274-3580 or through email.
